Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update

Ad Hoc Subcommitte of the American Academy of Neurology AIDS Task Force, 1991, Research Criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), Neurology, 41, 617, 10.1212/WNL.41.5.617 Alam, 1998, Electrophysiological studies in the Guillain–Barré syndrome: distinguishing subtypes by published criteria, Muscle Nerve, 2, 1275, 10.1002/(SICI)1097-4598(199810)21:10<1275::AID-MUS5>3.0.CO;2-8 Arnason, 1993, Acute inflammatory demyelinating polyradiculoneuropathy, 1437 Albers, 1985, Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy, Muscle Nerve, 8, 528, 10.1002/mus.880080609 Asbury, 1969, The inflammatory lesions in idiopathic polyneuritis: its role in pathogenesis, Medicine, 48, 173, 10.1097/00005792-196905000-00001 Asbury, 1978, Criteria for diagnosis of Guillain–Barré syndrome, Ann Neurol, 3, 565 Asbury, 1990, Assessment of current diagnostic criteria for Guillain–Barré syndrome, Ann Neurol, 27, S21, 10.1002/ana.410270707 Boërio-Guéguen, 2010, Distal nerve excitability and conduction studies in a case of rapidly regressive acute motor neuropathy with multiple motor conduction blocks, J Peripher Nerv Syst, 15, 369, 10.1111/j.1529-8027.2010.00285.x Bostock, 1994, Differences in behaviour of sensory and motor axons following release of ischemia, Brain, 117, 225, 10.1093/brain/117.2.225 Brown, 1993, The electrophysiological changes in the acute “axonal” form of Guillain–Barré syndrome, Muscle Nerve, 16, 200, 10.1002/mus.880160214 Capasso, 2003, Acute motor conduction block neuropathy: another Guillain–Barré syndrome variant, Neurology, 61, 617, 10.1212/WNL.61.5.617 Capasso, 2010, Reversible conduction failure in pharingeal-cervical-brachial variant of Guillain–Barré syndrome, Muscle Nerve, 42, 608, 10.1002/mus.21801 Capasso, 2011, Involvement of sensoryfibers in axonal subtypes of Guillain–Barré syndrome, J Neurol Neurosurg Psychiatry, 82, 664, 10.1136/jnnp.2010.238311 Caporale, 2006, Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain–Barré syndrome, J Neuroimmunol, 174, 12, 10.1016/j.jneuroim.2005.12.005 Cleland, 2006, Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis, Muscle Nerve, 33, 771, 10.1002/mus.20532 Corcia, 1999, Acute demyelinating motor neuropathy: an atypical form of the Guillain–Barré syndrome?, Rev Neurol (Paris), 155, 596 Cornblath, 1990, Electrophysiology in Guillain–Barré syndrome, Ann Neurol, 27, S517 Cornblath, 1992, Nerve conduction studies in amyotrophic lateral sclerosis, Muscle Nerve, 15, 1111, 10.1002/mus.880151009 Cornblath, 1991, Conduction block in neuropathies with necrotizing vasculitis, Muscle Nerve, 14, 184 De Angelis, 2001, Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier, J Neuroimmunol, 121, 79, 10.1016/S0165-5728(01)00434-9 Feasby, 1986, An acute axonal form of Guillain–Barré polyneuropathy, Brain, 109, 1115, 10.1093/brain/109.6.1115 Feasby, 1993, Severe degeneration in acute Guillain–Barré syndrome evidence of two different mechanisms, J Neurol Sci, 116, 185, 10.1016/0022-510X(93)90324-R Griffin, 1995, Guillain–Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases, Brain, 118, 577, 10.1093/brain/118.3.577 Griffin, 1996, Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain–Barré syndrome, J Neurocytol, 25, 33, 10.1007/BF02284784 Griffin, 1996, Pathology of the motor-sensory axonal Guillain–Barré syndrome, Ann Neurol, 39, 17, 10.1002/ana.410390105 Guillain, 1916, Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalorachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des reflexestendinex, Bull Soc Med Hop Paris, 40, 1462 Hadden, 1998, Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome, Ann Neurol, 44, 780, 10.1002/ana.410440512 Hafer-Macko, 1996, Acute motor axonal neuropathy: an antibody-mediated attack on axolemma, Ann Neurol, 40, 635, 10.1002/ana.410400414 Hiraga, 2005, Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome, Neurology, 64, 856, 10.1212/01.WNL.0000153071.71335.E9 Hiraga, 2005, Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome, J Neurol Neurosurg Psychiatry, 76, 719, 10.1136/jnnp.2004.051136 Hughes, 1997, Clinical and epidemiologic features of Guillain–Barré syndrome, J Infect Dis, 176, S92, 10.1086/513793 Ho, 1995, Guillain–Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies, Brain, 118, 597, 10.1093/brain/118.3.597 Ho, 1999, Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome, Ann Neurol, 45, 168, 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 Hong, 2011, Axonal conduction block at intermediate nerve segments in pure motor Guillain–Barré syndrome, J Peripher Nerv Syst, 16, 37, 10.1111/j.1529-8027.2011.00314.x Islam, 2010, Axonal variant of Guillain–Barré syndromeafter Campylobacter infection in Bangladesh, Neurology, 74, 581, 10.1212/WNL.0b013e3181cff735 Kalita, 2008, Neurophysiologic criteria in the diagnosis of different clinical types of Guillain–Barré syndrome, J Neurol Neurosurg Psychiatry, 79, 289, 10.1136/jnnp.2007.118000 Kaida, 2008, GM1/GalNAc-GD1a complex: a target for pure motor Guillain–Barré syndrome, Neurology, 71, 1683, 10.1212/01.wnl.0000335160.72184.7d Kiernan, 1996, Differences in recovery cycle of excitability in sensory and motor axons of human median nerve, Brain, 119, 1099, 10.1093/brain/119.4.1099 Kokubun, 2010, Conduction block in acute motor axonal neuropathy, Brain, 133, 2897, 10.1093/brain/awq260 Kushnir, 2008, Evolving pattern of Guillain–Barré syndrome in a community hospital in Israel, Acta Neurol Scand, 117, 347, 10.1111/j.1600-0404.2007.00949.x Kuwabara, 1998, IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome, Ann Neurol, 44, 202, 10.1002/ana.410440210 Kuwabara, 2001, Indicators of rapid clinical recovery in Guillain–Barré syndrome, J Neurol Neurosurg Psychiatry, 70, 560, 10.1136/jnnp.70.4.560 Kuwabara, 2004, Sensory nerve conduction in demyelinating and axonal Guillain–Barré syndromes, Eur Neurol, 51, 196, 10.1159/000078485 Kuwabara, 2007, Guillain–Barré syndrome, Curr Neurol Neurosci Rep, 7, 57, 10.1007/s11910-007-0022-6 Kuwabara, 2010, Axonal Guillain–Barré syndrome is underestimated in Europe?, J Neurol Neurosurg Psychiatry, 81, 1063, 10.1136/jnnp.2010.213421 Lambert, 1963, Nerve conduction in the Guillain–Barré syndrome, Bull Am Assoc Electromyogr Electrodiagn, 10, 13 Lopez, 2008, Structural requirements of anti-GD1a antibodies determine their target specificity, Brain, 131, 1926, 10.1093/brain/awn074 Lin, 2002, Responses of human sensory and motor axons to the release of ischaemia and to hyperpolarizing currents, J Physiol, 541, 1025, 10.1113/jphysiol.2002.017848 Lugaresi, 1997, Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis, J Neurol Sci, 147, 193, 10.1016/S0022-510X(96)05349-X McGonical, 2010, Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice, Brain, 133, 1944, 10.1093/brain/awq119 McCluskey, 1999, Pseudo-conduction block in vasculitic neuropathy, Muscle Nerve, 10, 1361, 10.1002/(SICI)1097-4598(199910)22:10<1361::AID-MUS4>3.0.CO;2-1 McKhann, 1993, Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China, Ann Neurol, 33, 333, 10.1002/ana.410330402 Mogyoros, 1996, Strength–duration properties of human peripheral nerve, Brain, 119, 439, 10.1093/brain/119.2.439 Nachamkin, 2007, Patterns of Guillain–Barré syndrome in children. Results from a Mexican population, Neurology, 69, 1665, 10.1212/01.wnl.0000265396.87983.bd Notturno, 2008, Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery, Muscle Nerve, 37, 265, 10.1002/mus.20875 Ogawa, 2009, Case of pure motor Guillain–Barré syndrome with motor conduction block andanti-GM1/GalNAc-GD1a antibody, Rinsho Shinkeigaku, 49, 488, 10.5692/clinicalneurol.49.488 Ogawara, 2000, Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan, Ann Neurol, 48, 624, 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O Osler, 1960, The Guillain–Barré syndrome: the need for exact diagnostic criteria, N Engl J Med, 262, 964, 10.1056/NEJM196005122621905 Rajabally, 2006, Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery, Neurology, 66, 287, 10.1212/01.wnl.0000194305.04983.ed Rajabally, 2011, Motor and sensory conduction failure in overlap of Guillain–Barré syndrome and Miller Fisher syndrome: two simultaneous cases, J Neurol Sci, 303, 35, 10.1016/j.jns.2011.01.019 Rees, 1995, Anti-ganglioside GM1 antibody in Guillain–Barré syndrome and their relationship to Campylobacter jejuni infection, Ann Neurol, 38, 809, 10.1002/ana.410380516 Sekiguchi, 2012, Anti-ganglioside antibodies are associated with axonal Guillain–Barré syndrome. A Japanese-Italian collaborative study, J Neurol Neurosurg Psychiatry, 83, 23, 10.1136/jnnp-2011-300309 Shafquat, 2006, Guillain–Barré syndrome in Pakistan: similarity of demyelinating and axonal variants, Eur J Neurol, 13, 662, 10.1111/j.1468-1331.2006.01071.x Sugie, 1998, A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis, Rinsho Shinkeigaku, 38, 42 Susuki, 2007, Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers, J Neurosci, 27, 3956, 10.1523/JNEUROSCI.4401-06.2007 Susuki, 2001, Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain–Barré syndrome associated with anti-GM1b IgG antibody, J Neurol, 248, 148, 10.1007/s004150170253 Uncini, 2006, Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery, Neurology, 67, 543, 10.1212/01.wnl.0000234967.76960.3c Uncini, 2009, Electrophysiologic and immunopathologic correlates in Guillain–Barré syndrome subtypes, Expert Rev Neurother, 9, 869, 10.1586/ern.09.43 Uncini, 2010, Pitfalls in electrodiagnosis of Guillain–Barré syndrome subtypes, J Neurol Neurosurg Psychiatry, 81, 1157, 10.1136/jnnp.2010.208538 Van der Meché, 1988, Patterns of conduction failure in the Guillain–Barré syndrome, Brain, 111, 405, 10.1093/brain/111.2.405 Van Asseldonk, 2005, Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy, Brain, 128, 880, 10.1093/brain/awh375 Van der Meché, 1991, Axonal damage in Guillain–Barré syndrome, Muscle Nerve, 14, 997, 10.1002/mus.880141011 Vucic, 2004, Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy, Clin Neurophysiol, 115, 2329, 10.1016/j.clinph.2004.05.009 White, 1996, Multifocal motor neuropathy with conduction block and Campylobacter jejuni, Neurology, 46, 562, 10.1212/WNL.46.2.562 Yuki, 1990, Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis, Neurology, 40, 1900, 10.1212/WNL.40.12.1900 Yuki, 1999, Acute motor axonal neuropathy and acute motor-sensory neuropathy share a common immunological profile, J Neurol Sci, 168, 121, 10.1016/S0022-510X(99)00180-X Yuki, 2001, Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside, Ann Neurol, 49, 712, 10.1002/ana.1012 Yuki, 2004, Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome, Proc Natl Acad Sci, 101, 1140, 10.1073/pnas.0402391101